SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-22-019844
Filing Date
2022-07-19
Accepted
2022-07-19 16:52:53
Documents
9
Period of Report
2022-07-19

Document Format Files

Seq Description Document Type Size
1 form6-k.htm 6-K 18716
2 ex99-1.htm EX-99.1 2983
3 ex99-2.htm EX-99.2 2106
4 form6-k_001.jpg GRAPHIC 2829
5 ex99-1_001.jpg GRAPHIC 164007
6 ex99-1_002.jpg GRAPHIC 179851
7 ex99-1_003.jpg GRAPHIC 120097
8 ex99-2_001.jpg GRAPHIC 262667
9 ex99-2_002.jpg GRAPHIC 510933
  Complete submission text file 0001493152-22-019844.txt   1733346
Mailing Address C/O STIKEMAN ELLIOTT LLP 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR MONTREAL A8 H3B 3V2
Business Address C/O STIKEMAN ELLIOTT LLP 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR MONTREAL A8 H3B 3V2 843-900-3201
Aeterna Zentaris Inc. (Filer) CIK: 0001113423 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38064 | Film No.: 221092032
SIC: 2834 Pharmaceutical Preparations